Bahri Ermis
Research Subjects
Research Interests
Bahri Ermis has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Abdulkadir Yildirim
Atatürk University
3 shared publicationsAyhan Tastekin
Atatürk University
2 shared publicationsBehzat Ozkan
Atatürk University
2 shared publicationsFatih Akcay
Atatürk University
2 shared publicationsFatma Demirel
2 shared publicationsRahmi Ors
2 shared publications
Latest Publications
- 1 January 2011
- Vol. 24 (9)
Early cardiac abnormalities and serum N-terminal pro B-type natriuretic peptide levels in obese children.
- 1 January 2011
- Vol. 24 (9)
Early cardiac abnormalities and serum N-terminal pro B-type natriuretic peptide levels in obese children.
- 1 September 2006
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 91 (5) , F373
Congenital medulloblastoma
- 1 September 2006
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 91 (5) , F373
Congenital medulloblastoma
- 1 January 2005
- Published by Springer Nature in Biological Trace Element Research
- Vol. 105 (1-3) , 027-036
Influence of Smoking on Serum and Milk Malondialdehyde, Superoxide Dismutase, Glutathione Peroxidase, and Antioxidant Potential Levels in Mothers at the Postpartum Seventh Day
The aim of the study was to investigate simultaneously serum and milk malondialdehyde (MDA) levels, superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, and antioxidant potential (AOP) in active-smoking, passive-smoking, and nonsmoking mothers and to search if there is any difference between serum and milk oxidant/ antioxidant status caused by smoking. According to their smoking status, 60 mothers (age range: 20–35 yr) were classified into one of three groups: the active-smoking mothers (n=15), the passive-smoking mothers (n=22), and the nonsmoking mothers (n=23). Serum and milk MDA, SOD, GPx, and AOP values were determined in mothers on the postpartum seventh day by the spectrophotometric method. Serum Zn and Cu concentrations were determined by atomic absorption spectrophotometry (AAS). There was no significant difference in serum samples with respect to MDA (p=0.17), SOD (p=0.51) and AOP (p=0.36) levels, but there was a significant difference in serum GPx (p=0.002) levels among the study groups. The significant differences were also found in milk samples in terms of MDA (p=0.002) and SOD (p=0.011), but not in GPx (p=0.11) and AOP (p=0.29) levels among the study groups. No significant difference was seen in serum zinc concentration (p=0.49), but copper concentration differed significantly among the groups (p=0.005). These observations suggest that human milk is more vulnerable to oxidative stress and lipid peroxidation than serum samples in smoking mothers, even if they are passive smokers.
- 1 January 2005
- Published by Springer Nature in Biological Trace Element Research
- Vol. 105 (1-3) , 027-036
Influence of Smoking on Serum and Milk Malondialdehyde, Superoxide Dismutase, Glutathione Peroxidase, and Antioxidant Potential Levels in Mothers at the Postpartum Seventh Day
The aim of the study was to investigate simultaneously serum and milk malondialdehyde (MDA) levels, superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, and antioxidant potential (AOP) in active-smoking, passive-smoking, and nonsmoking mothers and to search if there is any difference between serum and milk oxidant/ antioxidant status caused by smoking. According to their smoking status, 60 mothers (age range: 20–35 yr) were classified into one of three groups: the active-smoking mothers (n=15), the passive-smoking mothers (n=22), and the nonsmoking mothers (n=23). Serum and milk MDA, SOD, GPx, and AOP values were determined in mothers on the postpartum seventh day by the spectrophotometric method. Serum Zn and Cu concentrations were determined by atomic absorption spectrophotometry (AAS). There was no significant difference in serum samples with respect to MDA (p=0.17), SOD (p=0.51) and AOP (p=0.36) levels, but there was a significant difference in serum GPx (p=0.002) levels among the study groups. The significant differences were also found in milk samples in terms of MDA (p=0.002) and SOD (p=0.011), but not in GPx (p=0.11) and AOP (p=0.29) levels among the study groups. No significant difference was seen in serum zinc concentration (p=0.49), but copper concentration differed significantly among the groups (p=0.005). These observations suggest that human milk is more vulnerable to oxidative stress and lipid peroxidation than serum samples in smoking mothers, even if they are passive smokers.
- 1 December 2004
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 62 (6) , 288-292
Influence of Smoking on Serum and Milk of Mothers, and Their Infants’ Serum Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 Levels
Objective: To investigate the serum and milk in active-smoking and nonsmoking mothers, and their infants’ insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) levels. Design and Setting: A cohort study conducted at a tertiary medical center. Subjects: Forty-four mothers (age range: 21–34 years) and their newborns (7 days old) were enrolled in the study. Mothers were interviewed and classified according to their smoking status into one of two groups: the active-smoking mothers (n = 21) and the nonsmoking mothers (n = 23). Results: There was no difference noted in either IGF-I, IGFBP-3 or IGF-I/IGFBP-3 ratios in serum and milk of mothers, and their infants’ serum samples according to maternal smoking. Conclusion: This study demonstrated that maternal smoking (5–10 cigarettes/day) did not influence the maternal and infant serum levels of IGF-I and IGFBP-3 as well as the breast milk levels of these peptides.
- 1 December 2004
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 62 (6) , 288-292
Influence of Smoking on Serum and Milk of Mothers, and Their Infants’ Serum Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 Levels
Objective: To investigate the serum and milk in active-smoking and nonsmoking mothers, and their infants’ insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) levels. Design and Setting: A cohort study conducted at a tertiary medical center. Subjects: Forty-four mothers (age range: 21–34 years) and their newborns (7 days old) were enrolled in the study. Mothers were interviewed and classified according to their smoking status into one of two groups: the active-smoking mothers (n = 21) and the nonsmoking mothers (n = 23). Results: There was no difference noted in either IGF-I, IGFBP-3 or IGF-I/IGFBP-3 ratios in serum and milk of mothers, and their infants’ serum samples according to maternal smoking. Conclusion: This study demonstrated that maternal smoking (5–10 cigarettes/day) did not influence the maternal and infant serum levels of IGF-I and IGFBP-3 as well as the breast milk levels of these peptides.
- 1 January 2004
- Vol. 34 (4) , 405-9
Influence of smoking on maternal and neonatal serum malondialdehyde, superoxide dismutase, and glutathione peroxidase levels.
This cohort study investigated postnatal serum malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx) levels in 14 active-smoking, 14 passive-smoking, and 15 non-smoking mothers and their newborns on day 7 post-partum. No significant differences were noted among the study groups with respect to MDA (p = 0.63) or SOD levels (p = 0.98) in either the mothers or their infants. However, there were significant differences among the study groups with respect to serum GPx activities in both the mothers (p = 0.028) and the infants (p = 0.039). When GPx activities were analyzed separately in both mothers and infants, a significant difference was noted only between the infants of smoking mothers and the infants of non-smoking mothers (p = 0.015). In conclusion, there was a significant increase in GPx activities of smoking mothers and their infants, suggesting that they may have been exposed to more oxidant stress.
- 1 January 2004
- Vol. 34 (4) , 405-9
Influence of smoking on maternal and neonatal serum malondialdehyde, superoxide dismutase, and glutathione peroxidase levels.
This cohort study investigated postnatal serum malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx) levels in 14 active-smoking, 14 passive-smoking, and 15 non-smoking mothers and their newborns on day 7 post-partum. No significant differences were noted among the study groups with respect to MDA (p = 0.63) or SOD levels (p = 0.98) in either the mothers or their infants. However, there were significant differences among the study groups with respect to serum GPx activities in both the mothers (p = 0.028) and the infants (p = 0.039). When GPx activities were analyzed separately in both mothers and infants, a significant difference was noted only between the infants of smoking mothers and the infants of non-smoking mothers (p = 0.015). In conclusion, there was a significant increase in GPx activities of smoking mothers and their infants, suggesting that they may have been exposed to more oxidant stress.
- 1 September 2003
- Vol. 52 (3) , 240, 249
Image and diagnosis. Congenital diaphragmatic hernia.
- 1 May 2003
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 3 (5) , 287
Haemophagocytic syndrome following pseudomonas septicaemia
- 1 May 2003
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 3 (5) , 287
Haemophagocytic syndrome following pseudomonas septicaemia
- 1 January 2003
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 90 (07) , 158-159
Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use
- 1 January 2003
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 90 (07) , 158-159
Haemolytic anaemia secondary to trimethoprim/sulfamethoxazole use
- Open Access
- 1 October 2002
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 156 (10) , 995-998
A Randomized Placebo-Controlled Trial of Mebendazole for Halitosis
Objective To test whether mebendazole, an antiparasitic drug, would affect recovery from halitosis. Design We conducted a randomized, double-blind, placebo-controlled trial between April 1999 and September 2001. Setting A referral medical center. Patients One hundred sixty-two children aged 5 to 16 years whose parents complained about their chronic bad breath. Interventions Children were randomly assigned to receive mebendazole (n = 82) or placebo (n = 80). Main Outcome Measure Parents whose children had halitosis were evaluated for halitosis at 2 months of treatment by questionnaire. The microbiologist investigated the stool samples of children for parasitosis at the beginning of the trial and also at the end of the trial in children who were treated with mebendazole. Results Among those children who had evidence of parasites in stool samples at the beginning of the trial, 18 of 28 who were treated with mebendazole recovered from halitosis, compared with 2 of 24 who received placebo (relative risk [RR] for recovery, 7.7; 95% confidence interval [CI], 2.0-29.9). Among those who did not have stool parasites, 14 of 52 improved with mebendazole, compared with 10 of 48 taking placebo (RR, 1.3; 95% CI, 0.6-2.6). Mebendazole intake made a significant difference whether or not the children had parasites (P= .002). Conclusions Parasitosis should be considered as a possible cause of halitosis in the pediatric patient population. Mebendazole therapy seems to offer benefit to those children with parasites as a potential cause of their halitosis.
- 1 October 2002
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 156 (10) , 995-998
Open AccessA Randomized Placebo-Controlled Trial of Mebendazole for Halitosis
Objective To test whether mebendazole, an antiparasitic drug, would affect recovery from halitosis. Design We conducted a randomized, double-blind, placebo-controlled trial between April 1999 and September 2001. Setting A referral medical center. Patients One hundred sixty-two children aged 5 to 16 years whose parents complained about their chronic bad breath. Interventions Children were randomly assigned to receive mebendazole (n = 82) or placebo (n = 80). Main Outcome Measure Parents whose children had halitosis were evaluated for halitosis at 2 months of treatment by questionnaire. The microbiologist investigated the stool samples of children for parasitosis at the beginning of the trial and also at the end of the trial in children who were treated with mebendazole. Results Among those children who had evidence of parasites in stool samples at the beginning of the trial, 18 of 28 who were treated with mebendazole recovered from halitosis, compared with 2 of 24 who received placebo (relative risk [RR] for recovery, 7.7; 95% confidence interval [CI], 2.0-29.9). Among those who did not have stool parasites, 14 of 52 improved with mebendazole, compared with 10 of 48 taking placebo (RR, 1.3; 95% CI, 0.6-2.6). Mebendazole intake made a significant difference whether or not the children had parasites (P= .002). Conclusions Parasitosis should be considered as a possible cause of halitosis in the pediatric patient population. Mebendazole therapy seems to offer benefit to those children with parasites as a potential cause of their halitosis.
- Open Access
- 1 October 2002
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 48 (5) , 280-284
Effects of Three Different Iron Supplementations in Term Healthy Infants after 5 Months of Life
The aim of this study was to investigate the effects of different doses of iron on haematological status of breastfed infants. One hundred and thirteen infants were randomized into four groups at 5 months of age. Iron supplementation was given at doses of 1 mg/kg/day, 2 mg/kg/day, and 2 mg/kg/every other day in the first three study groups, respectively, and the last group received placebo. The hematological values, except hemoglobin, were higher in the group supplemented with iron at a dose of 2 mg/kg/day, and ferritin values were statistically higher in the group supplemented with iron at a dose of 2 mg/kg/every other day than in the group supplemented with iron at a dose of 1 mg/kg/day. We suggest that intermittent iron supplementation is more effective than a daily regimen in equal dosages.
- 1 October 2002
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 48 (5) , 280-284
Open AccessEffects of Three Different Iron Supplementations in Term Healthy Infants after 5 Months of Life
The aim of this study was to investigate the effects of different doses of iron on haematological status of breastfed infants. One hundred and thirteen infants were randomized into four groups at 5 months of age. Iron supplementation was given at doses of 1 mg/kg/day, 2 mg/kg/day, and 2 mg/kg/every other day in the first three study groups, respectively, and the last group received placebo. The hematological values, except hemoglobin, were higher in the group supplemented with iron at a dose of 2 mg/kg/day, and ferritin values were statistically higher in the group supplemented with iron at a dose of 2 mg/kg/every other day than in the group supplemented with iron at a dose of 1 mg/kg/day. We suggest that intermittent iron supplementation is more effective than a daily regimen in equal dosages.